Report: Working group to wade into debate over Ebola drug access

A new federal working group will take an initial step toward considering whether to allow the use of experimental anti-Ebola drugs on African patients, according to a report.

The Obama administration is setting up the group to weigh broad “principles of decision-making” for potentially expanding access to the drugs, Reuters reported.

{mosads}The White House is facing questions about the use of experimental Ebola treatments on two sick Americans. President Obama said Wednesday that it was “premature” to fast-track the drugs for approval.

“I think we’ve got to let the science guide us,” Obama said at a press conference at the U.S.-Africa summit in Washington, arguing that more testing needed to be done. “And you know, I don’t think all the information is in on whether this drug is helpful.”

Critics have charged that the drugs should be made available to victims everywhere.

The new working group will operate under the umbrella of the Department of Health and Human Services and its Assistant Secretary for Preparedness and Response Nicole Lurie.

See all Hill.TV See all Video